Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees

SARS-CoV-2 vaccines, administered to billions of people worldwide, mitigate the effects of the COVID-19 pandemic, however little is known about the molecular basis of antibody cross-protection to emerging variants, such as Omicron BA.1, its sublineage BA.2, and other coronaviruses. To answer this qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Andreano, Emanuele, Paciello, Ida, Marchese, Silvia, Donnici, Lorena, Pierleoni, Giulio, Piccini, Giulia, Manganaro, Noemi, Pantano, Elisa, Abbiento, Valentina, Pileri, Piero, Benincasa, Linda, Giglioli, Ginevra, Leonardi, Margherita, Maes, Piet, De Santi, Concetta, Sala, Claudia, Montomoli, Emanuele, De Francesco, Raffaele, Rappuoli, Rino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189263/
https://www.ncbi.nlm.nih.gov/pubmed/35697673
http://dx.doi.org/10.1038/s41467-022-31115-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189263/
https://www.ncbi.nlm.nih.gov/pubmed/35697673
http://dx.doi.org/10.1038/s41467-022-31115-8

Ejemplares similares